{"title": "CONTROL-COVID", "author_url": "http://www.tibdn.ca/author/admin", "html": "<p>\r\n\t<span style=\"font-size:20px;\"><span><strong><span><a href=\"/control-covid/ltc\">Control of Covid-19 outbreaks in Long Term Care</a></span></strong></span></span></p>\r\n<!-- <p>\r\n\tThis is a placebo-controlled cluster-randomized trial to evaluate the efficacy of favipiravir and hydroxychloroquine chemoprophylaxis for control of COVID-19 outbreaks in long-term care homes (LTCH). <a href=\"/control-covid/ltc\">Read more...</a></p>\r\n<p>\r\n\tSTUDY 1: <a href=\"/control-covid/files/favipiravir-info/at_download/file\">Favipiravir</a> versus placebo for residents; hydroxychloroquine versus placebo for staff</p>\r\n<p>\r\n\t&nbsp;</p>\r\n<p>\r\n\t<a href=\"/control-covid/files/protocol/at_download/file\"><code>Protocol</code></a> <code>Short Summary</code> <a href=\"/control-covid/ltc\"><code>Q&amp;A</code></a> <code>Collaborators</code></p>\r\n-->", "version": "1.0", "type": "rich", "provider_name": "TIBDN: Toronto Invasive Bacterial Diseases Network", "provider_url": "http://www.tibdn.ca", "author_name": ""}